Dr. Lal PathLabs Limited

NSE:LALPATHLAB.NS

3312.7 (INR) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q3
Revenue 6,0195,4545,3896,0135,4104,9104,8945,3385,0274,853.794,9694,9846,0664,309.664,5244,3192,6603,016.573,2793,6563,3523,011.182,9253,1752,9232,6682,6272,7812,4932,1992,074.22,621.62,228.31,977.11,885.62,157.11,892.91,718.71,558
Cost of Revenue 3,5443,2651,8472,0761,8761,0591,1091,9051,8383,983.921,1891,2441,4511,032.611,0981,083759720.04744811712651.51653677642575570594521449.9440.9596.2483.8431.6416.5485.8395.3372.38335.8
Gross Profit 2,4752,1893,5423,9373,5343,8513,7853,4333,189869.873,7803,7404,6153,277.053,4263,2361,9012,296.532,5352,8452,6402,359.672,2722,4982,2812,0932,0572,1871,9721,749.11,633.32,025.41,744.51,545.51,469.11,671.31,497.61,346.321,222.2
Gross Profit Ratio 0.4110.4010.6570.6550.6530.7840.7730.6430.6340.1790.7610.750.7610.760.7570.7490.7150.7610.7730.7780.7880.7840.7770.7870.780.7840.7830.7860.7910.7950.7870.7730.7830.7820.7790.7750.7910.7830.784
Reseach & Development Expenses 00000000000000000000000000000000000000.9850
General & Administrative Expenses 837756777852745688.34693743696582.4643699921584.83604561293392.85421480436371.57374399365329.52318334294334.31201.7248.9216.1546.6177.2198.3171.1418.9130.1
Selling & Marketing Expenses 2853522692530507.83063430367.640019307.21000341.54000352.68000337.87000252.22000190.849000182.0180
SG&A 1,1221,1081,0461,1057451,0829991,0866961,216.766436999401,042.79604561293885.284214804361,202.513743993651,155.773183342941,027201.7248.9216.133.682177.2198.3171.178.347130.1
Other Expenses 206-2,946183181144-546-58887831,860.69-522-556-780-946.23-469-432-179-819.91-283-332-292-691.18-252-290-271-241-247-257-219-192.7-134.6-186.2-156-135.8-133-147.6-130331.58-98.1
Operating Expenses 1,1221,1082,4962,5182,4232,3832,3412,3832,3732,286.062,3521,8311,9961,666.031,6291,5981,3041,469.991,4791,4531,4161,368.441,3381,3251,2541,2301,2531,1491,0921,080.71,032.61,045.4989.1879.2665.61,181.18991,396.06782.4
Operating Income 1,3531,0811,2291,6001,1119228561,137816855.087851,2102,6191,611.021,7971,638418826.541,0561,3921,224991.239341,1731,0278638041,038880668.4600.7980755.4666.3803.5490.2598.6-49.74439.8
Operating Income Ratio 0.2250.1980.2280.2660.2050.1880.1750.2130.1620.1760.1580.2430.4320.3740.3970.3790.1570.2740.3220.3810.3650.3290.3190.3690.3510.3230.3060.3730.3530.3040.290.3740.3390.3370.4260.2270.316-0.0290.282
Total Other Income Expenses Net 146118-70-7864-90-91-109-2-19.263096-826-502.93-508-472-37-372.51-322-369-330-299.75-255-292-273-243-249-260-220-193.8-135.6-186.2-156.1-138.532.8-315.4-130.3439.92-98.2
Income Before Tax 1,4991,1991,1591,5221,1758327651,028814835.828151,3061,7931,108.091,2891,166381454.037341,023894691.48679881754620555778660474.6465.1793.8599.3527.8836.3174.8468.3390.18341.6
Income Before Tax Ratio 0.2490.220.2150.2530.2170.1690.1560.1930.1620.1720.1640.2620.2960.2570.2850.270.1430.1510.2240.280.2670.230.2320.2770.2580.2320.2110.280.2650.2160.2240.3030.2690.2670.4440.0810.2470.2270.219
Income Tax Expense 421341337415339263229304232214.91233343456257.333029597128.16185213303217.81218307257218192269216163155.1265.3197.6181.3225.2109.9158.5117.01113.1
Net Income 1,064845.358131,093826567528717577613.335739501,312834.21945853284325.41541805588470.8458570494401360506441309.9308.7525.1398.2344.4608.261.9307.4273.04226.6
Net Income Ratio 0.1770.1550.1510.1820.1530.1150.1080.1340.1150.1260.1150.1910.2160.1940.2090.1970.1070.1080.1650.220.1750.1560.1570.180.1690.150.1370.1820.1770.1410.1490.20.1790.1740.3230.0290.1620.1590.145
EPS 12.7810.139.7713.169.956.826.378.646.967.416.9311.4915.8710.111.4410.343.453.946.569.777.145.715.566.9264.884.396.195.43.853.786.474.884.177.370.995.613.314.21
EPS Diluted 12.7610.129.7613.129.936.826.358.66.967.416.911.4515.8410.111.4110.313.443.946.559.757.135.715.556.9164.874.396.185.43.843.756.434.854.147.310.753.723.312.77
EBITDA 1,7001,4471,5891,9591,6061,2981,2351,5251,2581,331.711,2131,5582,0311,355.11,5231,401597693.259611,2371,095797.07778977844729637856730554.9536.8860.9664.1603.1744.8413.9533.2478.47414.8
EBITDA Ratio 0.2820.2650.2950.3260.2970.2640.2520.2860.250.2740.2440.3130.3350.3140.3370.3240.2240.230.2930.3380.3270.2650.2660.3080.2890.2730.2420.3080.2930.2520.2590.3280.2980.3050.3950.1920.2820.2780.266